Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Olga Y. Volkova"'
Autor:
Sergey V. Guselnikov, Konstantin O. Baranov, Sergey V. Kulemzin, Tatyana N. Belovezhets, Anton N. Chikaev, Svetlana V. Murasheva, Olga Y. Volkova, Ludmila V. Mechetina, Alexander M. Najakshin, Nikolai A. Chikaev, Pavel P. Solodkov, Maria V. Sergeeva, Alexander V. Smirnov, Irina A. Serova, Oleg L. Serov, Alexander G. Markhaev, Yulia V. Kononova, Alexander Y. Alekseev, Marina A. Gulyaeva, Daria M. Danilenko, Nariman R. Battulin, Alexander M. Shestopalov, Alexander V. Taranin
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The COVID-19 pandemic has uncovered the high genetic variability of the SARS-CoV-2 virus and its ability to evade the immune responses that were induced by earlier viral variants. Only a few monoclonal antibodies that have been reported to date are c
Externí odkaz:
https://doaj.org/article/6da10109f6fb4cc2aa3729d2219d4170
Autor:
Pavel P. Solodkov, Alexander M. Najakshin, Nikolai A. Chikaev, Sergey V. Kulemzin, Ludmila V. Mechetina, Konstantin O. Baranov, Sergey V. Guselnikov, Andrey A. Gorchakov, Tatyana N. Belovezhets, Anton N. Chikaev, Olga Y. Volkova, Alexander G. Markhaev, Yulia V. Kononova, Alexander Y. Alekseev, Marina A. Gulyaeva, Alexander M. Shestopalov, Alexander V. Taranin
Publikováno v:
Vaccines, Vol 12, Iss 2, p 129 (2024)
The emergence of SARS-CoV-2 mutant variants has posed a significant challenge to both the prevention and treatment of COVID-19 with anti-coronaviral neutralizing antibodies. The latest viral variants demonstrate pronounced resistance to the vast majo
Externí odkaz:
https://doaj.org/article/3f932639df4445969276ce69457f349c
Autor:
Sergey V. Kulemzin, Sergey V. Guselnikov, Boris G. Nekrasov, Svetlana V. Molodykh, Irina N. Kuvshinova, Svetlana V. Murasheva, Tatyana N. Belovezhets, Andrey A. Gorchakov, Anton N. Chikaev, Nikolai A. Chikaev, Olga Y. Volkova, Anna A. Yurina, Alexander M. Najakshin, Alexander V. Taranin
Publikováno v:
Vaccines, Vol 12, Iss 1, p 55 (2024)
SARS-CoV-2 has a relatively high mutation rate, with the frequent emergence of new variants of concern (VOCs). Each subsequent variant is more difficult to neutralize by the sera of vaccinated individuals and convalescents. Some decrease in neutraliz
Externí odkaz:
https://doaj.org/article/aad5822efb674e47a6cbbe12f6831599
Autor:
Evgenii L. Zavjalova, Dmitry A. Gruzdev, V. V. Kanygin, Rinat Mukhamadiyarov, Tatiana Guselnikova, Olga Y. Volkova, Galina L. Levit, Ivan A. Razumov, Andrey A. Ponomarev, Victor P. Krasnovc, O. I. Solovieva, A. I. Kichigin, Ludmila V. Mechetina, Alphiya R. Tsygankova, Anna I. Kasatova, Angelina A. Telegina
Publikováno v:
Mendeleev Communications. 31:659-661
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94341278f5a29ff23825dc05a0992c6d
https://doi.org/10.1016/j.mencom.2021.09.022
https://doi.org/10.1016/j.mencom.2021.09.022
Autor:
Denis V. Antonets, Larisa I. Karpenko, Ekaterina V Starostina, Tatyana N. Ilyicheva, Olga Y. Volkova, Bazhan Si, Olga N. Kaplina, Anastasiya Yu. Bakulina, Vasiliy Y. Marchenko
Publikováno v:
Journal of Biomolecular Structure and Dynamics. 40:3196-3212
The polyepitope strategy is promising approach for successfully creating a broadly protective flu vaccine, which targets T-lymphocytes (both CD4+ and CD8+) to recognise the most conserved epitopes of viral proteins. In this study, we employed a compu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03f8e3a1f8743e97e8bcfa4388abda93
https://doi.org/10.1080/07391102.2020.1845978
https://doi.org/10.1080/07391102.2020.1845978
Autor:
Pavel P. Solodkov, Olga Y. Volkova, Alexander Yu. Alekseyev, Anton N. Chikaev, Alexander Shestopalov, G. M. Yusubalieva, Alexander V. Taranin, Yulia V. Kononova, Sergey Guselnikov, Chikaev Na, Marina A. Gulyaeva, Andrey A. Gorchakov, Konstantin O Baranov, Tatyana N. Belovezhets, Tatiana V. Klypa, Vladimir P. Baklaushev, Vladimir T. Valuev-Elliston, Alexander M. Najakshin, Alexander G. Markhaev, Sergey V. Kulemzin, Alexander V. Ivanov, Victor F. Larichev, Ludmila V. Mechetina
Publikováno v:
Cell Discovery
Cell Discovery, Vol 7, Iss 1, Pp 1-15 (2021)
Cell Discovery, Vol 7, Iss 1, Pp 1-15 (2021)
In the absence of virus-targeting small-molecule drugs approved for the treatment and prevention of COVID-19, broadening the repertoire of potent SARS-CoV-2-neutralizing antibodies represents an important area of research in response to the ongoing p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46aa54d8440fb55b206445a517845af
https://pubmed.ncbi.nlm.nih.gov/34667147
https://pubmed.ncbi.nlm.nih.gov/34667147
Autor:
A. Taranin, A. V. Tkachenko, Daria A. Matvienko, Tatyana N. Belovezhets, Olga Y. Volkova, Elena V. Kuligina, Vladimir A. Richter, Olga A. Koval
Publikováno v:
Genes & Cells. 13:89-93
Development of efficient antitumor modalities remains a priority of modern translation medicine. Adoptive transfer of autologous T cells expressing chimeric antigen receptors (CARs) specific for tumor-associated surface targets of B cells has demonst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33577a7ecfcaef463be277b953e1d1fe
https://doi.org/10.23868/201811039
https://doi.org/10.23868/201811039
Autor:
Anna S. Smagina, Anton N. Chikaev, Daria A. Matvienko, Alexandr V. Taranin, Elena V. Kuligina, Tatyana N. Belovezhets, Sergey V. Kulemzin, Olga Y. Volkova, Andrey A. Gorchakov, Olga A. Koval, Nikolay A. Chikaev
Publikováno v:
Cellular Therapy and Transplantation. 7:70-77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0582f62f95364f69b8f0ac95a3f8bd5e
https://doi.org/10.18620/ctt-1866-8836-2018-7-2-70-77
https://doi.org/10.18620/ctt-1866-8836-2018-7-2-70-77
Autor:
Valeriya V Kuznetsova, Sergey V. Kulemzin, Daria A. Matvienko, Alexey Petukhov, Olga Y. Volkova, Andrey Zaritskey, Andrey A. Gorchakov, Anton N. Chikaev, Alexandr V. Taranin
Publikováno v:
Oncotarget
T and NK cells armed with chimeric antigen receptors (CAR) are promising tools for the specific elimination of cancer cells. In most CAR designs implemented to date, the recognition of target cells is mediated by single-chain variable fragments (scFv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe3b4748b35f6c2220817bdda4c9b4fd
http://europepmc.org/articles/PMC5823625
http://europepmc.org/articles/PMC5823625
Autor:
Alexandr V. Taranin, Elena V. Kuligina, Olga A. Koval, Sergey V. Kulemzin, Anna A. Nushtaeva, Vladimir A. Richter, Andrey A. Gorchakov, A. V. Tkachenko, Olga Y. Volkova
Publikováno v:
Vavilovskij Žurnal Genetiki i Selekcii, Vol 21, Iss 7, Pp 764-769 (2017)
Despite the multitude of anticancer cytostatic drugs available to oncologists today, most of such drugs have serious side effects that may preclude their use in some groups of patients. Hence, selective induction of apoptosis in cancer but not normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2831d24c1ef3b4cd9400152adb959f91
https://vavilov.elpub.ru/jour/article/view/1222
https://vavilov.elpub.ru/jour/article/view/1222